Skip to search formSkip to main contentSkip to account menu

cefepime

Known as: Cefepima, cefepim, cefepime [Chemical/Ingredient] 
A semisynthetic, broad-spectrum, fourth-generation cephalosporin with antibacterial activity. Cefepime binds to and inactivates penicillin-binding… 
National Institutes of Health

Related topics

Related topics

32 relations
Acinetobacter InfectionsBacterial InfectionsBone Diseases, InfectiousCefepime Islt KB

Broader (1)

Anti-Bacterial Agents

Narrower (3)

BMY 28142MaxipimeQuadrocef

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Development and Validation of RP–HPLC Method for Simultaneous Estimation of Cefepime and Tazobactam in Injection Formulation
A new, rapid, highly sensitive, economical and accurate RP-HPLC method was developed for simultaneous estimation of Cefepime and… 
2012
2012
Falla orgánica múltiple por estrongiloidiasis diseminada: Comunicación de un caso
Resumen Se presenta el caso de un paciente masculino, de 50 anos, con antecedentes de alcoholismo, procedente de area rural, que… 
2012
2012
Opium Syrup Distribution, Limitation and Challenges
Addiction is one of dilemmas in the current society. Formal statistics report of 2 million addict people in the country. Among… 
2011
2011
In Vitro Efficacy of Cefepime Against Multi-Drug Resistant Pseudomonas aeruginosa – An Alarming Situation in our Setup
Background: Third generation cephalosporins are still most commonly used antibiotics empirically in our setup leading to… 
2007
2007
Selective immediate hypersensitivity to cefepime.
Cefepime is a fourth-generation cephalosporin with a broad antimicrobial spectrum and good activity against both gram-positive… 
2005
2005
Acquiring resistance to a specific antibiotic provides a clear benefit to the bacterium Is Bacterial Resistance to Antibiotics an Appropriate Example of Evolutionary Change ?
Evolutionists frequently point to the development of antibiotic resistance by bacteria as a demonstration of evolutionary change… 
2005
2005
A FIVE-YEAR RETROSPECTIVE STUDY ON THE COMMON MICROBIAL ISOLATES AND SENSITIVITY PATTERN ON BLOOD CULTURE OF PEDIATRIC CANCER PATIENTS ADMITTED AT THE PHILIPPINE GENERAL HOSPITAL FOR FEBRILE…
Rationale: Febrile neutropenia is a common clinical problem among pediatric cancer patients. This often necessitates… 
Review
2001
Review
2001
[Cefepime (maxipime), large spectrum 4th generation cephalosporin, resistant to beta-lactamases].
As a result of the appearance of bacterial strains resistant to 3rd generation cephlosporin, since 1993 cephalosporins of 4th… 
1992
1992
Serum concentrations of cefepime (BMY-28142), a broad-spectrum cephalosporin, in dogs.
Serum concentrations of cefepime (BMY-28142) were determined for four dosing regimes, 10 mg/kg or 20 mg/kg, given as single… 
1989
1989
Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Cefepime (BMY-28142), a new semisynthetic cephalosporin, was evaluated for in vitro and in vivo antibacterial activities in…